Eye cancer treatment with targeted therapy

Cancerous cells require many different components to maintain their development and growth. Eye cancer cells are more or less the same. So, oncologists decided to try some methods to interrupt the flow of these components into cells. And surprisingly, received pretty good results. These methods target some components, and, as a result, tumors lose supply, can't activate or produce some specific substances, and stop growing and spreading. That's why all these new methods were called targeted therapy. Before starting targeted therapy, it's always necessary to know as much information about the tumor's features as possible. That's because the efficiency of targeted therapy depends on the genetic specifics of the patient's organism and particular mutations of the cancer's genome. Currently, proteasome inhibitors, signal transduction inhibitors, angiogenesis inhibitors, and monoclonal antibodies are among the most widely used groups of drugs for targeted therapy. They might be combined with other treatment methods or as a single therapy. Some targeted therapy medications might be pills, capsules, or tablets. But, primarily, they are delivered via intravenous injections or droppers. A single procedure often might take up to a few hours. Patients will also need to receive symptomatic therapy to decrease the severity of cancer-related symptoms (e. g. , pain, decreased appetite, etc. ).